Follitropin delta

Therapeutic indications

Follitropin delta is indicated for:

Controlled ovarian stimulation

Population group: women, only adults (18 - 65 years old)

Controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Follitropin delta is contraindicated in the following cases:

Tumours of the hypothalamus, tumours of pituitary gland

at least one of
Tumor of hypothalamus
Neoplasm of pituitary gland

Ovarian enlargement, ovarian cyst

at least one of
Ovarian enlargement
Ovarian cyst and additionally not Polycystic ovary

Gynaecological haemorrhages

Genitourinary tract hemorrhage

Ovarian, uterine, mammary carcinoma

at least one of
Malignant tumour of ovary
Malignant neoplasm of uterus
Malignant tumor of breast

Primary ovarian failure

Primary ovarian failure

Malformations of sexual organs

Congenital malformation of uterus and cervix

Fibroid tumours of the uterus

Uterine leiomyoma

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2017: REKOVELLE Solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈